{"transactions":[{"id":776873,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-15T20:25:33.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":33222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU was granted on May 14, 2026, under the 2020 Incentive Plan that entitles the reporting person to receive one share of issuer's common stock per RSU. The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each RSU was granted on May 14, 2026, under the 2020 Incentive Plan that entitles the reporting person to receive one share of issuer's common stock per RSU. The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each RSU was granted on May 14, 2026, under the 2020 Incentive Plan that entitles the reporting person to receive one share of issuer's common stock per RSU. The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual meeting."}],"balance_after":33222,"derivative":{"underlying":"Common Stock","underlying_shares":33222},"source":{"system":"sec-edgar","filing":"0001269428-26-000002","document":"form4-05152026_080529.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000126942826000002/form4-05152026_080529.xml","form_type":"4"}},{"id":776872,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-15T20:25:33.000Z","date":"2026-05-14","kind":"exercise","planned":false,"acquired":false,"shares":15757,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 21, 2025, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 14, 2026, the day of the issuer's annual meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 21, 2025, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 14, 2026, the day of the issuer's annual meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 21, 2025, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 14, 2026, the day of the issuer's annual meeting."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":15757},"source":{"system":"sec-edgar","filing":"0001269428-26-000002","document":"form4-05152026_080529.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000126942826000002/form4-05152026_080529.xml","form_type":"4"}},{"id":776871,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:25:33.000Z","date":"2026-05-14","kind":"exercise","planned":false,"acquired":true,"shares":15757,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 21, 2025, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 14, 2026, the day of the issuer's annual meeting."}],"balance_after":213316,"source":{"system":"sec-edgar","filing":"0001269428-26-000002","document":"form4-05152026_080529.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000126942826000002/form4-05152026_080529.xml","form_type":"4"}},{"id":819260,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-04-02T20:13:10.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":false,"shares":21546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of Organon common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 31, 2025, the Reporting Person was granted 64,640 RSUs. One-third of such RSUs vested on March 31, 2026, with the remaining two-thirds to vest on March 31, 2027 and March 31, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 31, 2025, the Reporting Person was granted 64,640 RSUs. One-third of such RSUs vested on March 31, 2026, with the remaining two-thirds to vest on March 31, 2027 and March 31, 2028."}],"balance_after":43094,"derivative":{"underlying":"Common Stock","underlying_shares":21546},"source":{"system":"sec-edgar","filing":"0001628280-26-023157","document":"wk-form4_1775160787.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000162828026023157/wk-form4_1775160787.xml","form_type":"4"}},{"id":819259,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-04-02T20:13:10.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":false,"shares":12047,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of Organon common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 31, 2023, the Reporting Person was granted 36,139 RSUs. Two-thirds of such RSUs previously vested, and the remaining one-third vested on March 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On March 31, 2023, the Reporting Person was granted 36,139 RSUs. Two-thirds of such RSUs previously vested, and the remaining one-third vested on March 31, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":12047},"source":{"system":"sec-edgar","filing":"0001628280-26-023157","document":"wk-form4_1775160787.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000162828026023157/wk-form4_1775160787.xml","form_type":"4"}},{"id":819258,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-04-02T20:13:10.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":83472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On March 31, 2026, the Reporting Person was granted 83,472 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 31, 2026, the Reporting Person was granted 83,472 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On March 31, 2026, the Reporting Person was granted 83,472 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029."}],"balance_after":83472,"derivative":{"underlying":"Common Stock","underlying_shares":83472},"source":{"system":"sec-edgar","filing":"0001628280-26-023157","document":"wk-form4_1775160787.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000162828026023157/wk-form4_1775160787.xml","form_type":"4"}},{"id":819257,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-04-02T20:13:10.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":321368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On March 31, 2026, the Reporting Person was granted 321,368 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 31, 2026, the Reporting Person was granted 321,368 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 31, 2026, the Reporting Person was granted 321,368 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029."}],"balance_after":321368,"derivative":{"underlying":"Common Stock","underlying_shares":321368},"source":{"system":"sec-edgar","filing":"0001628280-26-023157","document":"wk-form4_1775160787.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000162828026023157/wk-form4_1775160787.xml","form_type":"4"}},{"id":819256,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-02T20:13:10.000Z","date":"2026-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":7380,"price":5.7,"value":42066.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price is the closing market price of Organon & Co. (\"Organon\") common stock on Monday, March 30, 2026, as required by the plan under which the Restricted Stock Units (\"RSU\") were awarded."}],"balance_after":212746,"source":{"system":"sec-edgar","filing":"0001628280-26-023157","document":"wk-form4_1775160787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000162828026023157/wk-form4_1775160787.xml","form_type":"4"}},{"id":819255,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-02T20:13:10.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":true,"shares":21546,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":220126,"source":{"system":"sec-edgar","filing":"0001628280-26-023157","document":"wk-form4_1775160787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000162828026023157/wk-form4_1775160787.xml","form_type":"4"}},{"id":819254,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-02T20:13:10.000Z","date":"2026-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":4127,"price":5.7,"value":23523.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price is the closing market price of Organon & Co. (\"Organon\") common stock on Monday, March 30, 2026, as required by the plan under which the Restricted Stock Units (\"RSU\") were awarded."}],"balance_after":198580,"source":{"system":"sec-edgar","filing":"0001628280-26-023157","document":"wk-form4_1775160787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000162828026023157/wk-form4_1775160787.xml","form_type":"4"}},{"id":819253,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-02T20:13:10.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":true,"shares":12047,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":202707,"source":{"system":"sec-edgar","filing":"0001628280-26-023157","document":"wk-form4_1775160787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000162828026023157/wk-form4_1775160787.xml","form_type":"4"}},{"id":824008,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-31T20:06:58.000Z","date":"2026-03-29","kind":"exercise","planned":false,"acquired":false,"shares":15071,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of Organon common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027."}],"balance_after":15071,"derivative":{"underlying":"Common Stock","underlying_shares":15071},"source":{"system":"sec-edgar","filing":"0001628280-26-022377","document":"wk-form4_1774987616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000162828026022377/wk-form4_1774987616.xml","form_type":"4"}},{"id":824007,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-31T20:06:58.000Z","date":"2026-03-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":5162,"price":5.84,"value":30146.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the closing market price of Organon & Co. (\"Organon\") common stock on Friday, March 27, 2026, as required by the plan under which the Restricted Stock Units (\"RSU\") were awarded."}],"balance_after":190660,"source":{"system":"sec-edgar","filing":"0001628280-26-022377","document":"wk-form4_1774987616.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000162828026022377/wk-form4_1774987616.xml","form_type":"4"}},{"id":824006,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-31T20:06:58.000Z","date":"2026-03-29","kind":"exercise","planned":false,"acquired":true,"shares":15071,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":195822,"source":{"system":"sec-edgar","filing":"0001628280-26-022377","document":"wk-form4_1774987616.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000162828026022377/wk-form4_1774987616.xml","form_type":"4"}},{"id":866046,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-04T00:01:47.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":4117,"price":7.23,"value":29765.91,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes the addition of 652 shares of Common Stock acquired from dividend equivalents net of withholding tax not previously required to be reported."}],"balance_after":180751,"source":{"system":"sec-edgar","filing":"0001628280-26-014228","document":"wk-form4_1772582504.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000162828026014228/wk-form4_1772582504.xml","form_type":"4"}},{"id":866045,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-04T00:01:47.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":12020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares of Common Stock released to cover the dividend equivalents earned on the PSUs released above."}],"balance_after":184216,"source":{"system":"sec-edgar","filing":"0001628280-26-014228","document":"wk-form4_1772582504.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000162828026014228/wk-form4_1772582504.xml","form_type":"4"}},{"id":866044,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-04T00:01:47.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":14887,"price":7.17,"value":106739.79,"ownership":{"direct":true},"balance_after":172196,"source":{"system":"sec-edgar","filing":"0001628280-26-014228","document":"wk-form4_1772582504.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000162828026014228/wk-form4_1772582504.xml","form_type":"4"}},{"id":866043,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-04T00:01:47.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":42599,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Organon & Co. common stock (\"Common Stock\") for performance share units (\"PSUs\") granted to the reporting person on August 11, 2023 under the Organon & Co. 2021\nIncentive Stock Plan. The performance-vesting restrictions with respect to these shares were released upon certification of performance goal attainment by the Talent Committee of Organon's Board of\nDirectors."}],"balance_after":187083,"source":{"system":"sec-edgar","filing":"0001628280-26-014228","document":"wk-form4_1772582504.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000162828026014228/wk-form4_1772582504.xml","form_type":"4"}},{"id":1136871,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-22T21:07:31.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":15757,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU was granted on May 21, 2025, under the 2020 Incentive Plan that entitles the reporting person to receive one share of issuer's common stock per RSU. The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each RSU was granted on May 21, 2025, under the 2020 Incentive Plan that entitles the reporting person to receive one share of issuer's common stock per RSU. The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each RSU was granted on May 21, 2025, under the 2020 Incentive Plan that entitles the reporting person to receive one share of issuer's common stock per RSU. The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual meeting."}],"balance_after":15757,"derivative":{"underlying":"Common Stock","underlying_shares":15757},"source":{"system":"sec-edgar","filing":"0001415889-25-014194","document":"form4-05222025_090526.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000141588925014194/form4-05222025_090526.xml","form_type":"4"}},{"id":1136870,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-22T21:07:31.000Z","date":"2025-05-21","kind":"exercise","planned":false,"acquired":false,"shares":11928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 21, 2024, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 21, 2025, the day of the issuer's annual meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 21, 2024, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 21, 2025, the day of the issuer's annual meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 21, 2024, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 21, 2025, the day of the issuer's annual meeting."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11928},"source":{"system":"sec-edgar","filing":"0001415889-25-014194","document":"form4-05222025_090526.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000141588925014194/form4-05222025_090526.xml","form_type":"4"}},{"id":1136869,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T21:07:31.000Z","date":"2025-05-21","kind":"exercise","planned":false,"acquired":true,"shares":11928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 21, 2024, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 21, 2025, the day of the issuer's annual meeting."}],"balance_after":197559,"source":{"system":"sec-edgar","filing":"0001415889-25-014194","document":"form4-05222025_090526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000141588925014194/form4-05222025_090526.xml","form_type":"4"}},{"id":1157258,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-06T17:59:28.000Z","date":"2025-05-05","kind":"purchase","planned":false,"acquired":true,"shares":11400,"price":8.82,"value":100548.0,"ownership":{"direct":true},"balance_after":144484,"source":{"system":"sec-edgar","filing":"0001821825-25-000027","document":"wk-form4_1746554362.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182525000027/wk-form4_1746554362.xml","form_type":"4"}},{"id":1182968,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-04-02T21:41:53.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":false,"shares":7754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU converts into one share of Organon common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On March 31, 2022, RSUs were awarded and on March 31, 2025, the final third of these RSUs vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On March 31, 2022, RSUs were awarded and on March 31, 2025, the final third of these RSUs vested."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7754},"source":{"system":"sec-edgar","filing":"0001821825-25-000014","document":"wk-form4_1743630106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182525000014/wk-form4_1743630106.xml","form_type":"4"}},{"id":1182967,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-04-02T21:41:53.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":false,"shares":12046,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU converts into one share of Organon common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 31, 2023, RSUs were awarded and on March 31, 2025, one-third of these RSUs vested with the remaining RSUs to vest on March 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 31, 2023, RSUs were awarded and on March 31, 2025, one-third of these RSUs vested with the remaining RSUs to vest on March 31, 2026."}],"balance_after":12047,"derivative":{"underlying":"Common Stock","underlying_shares":12046},"source":{"system":"sec-edgar","filing":"0001821825-25-000014","document":"wk-form4_1743630106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182525000014/wk-form4_1743630106.xml","form_type":"4"}},{"id":1182966,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-04-02T21:41:53.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":false,"shares":15070,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU converts into one share of Organon common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 29, 2024, RSUs were granted and on March 29, 2025, one-third of these RSUs vested, with the remaining RSUs to vest on March 29, 2026, and March 29, 2027. Since the first anniversary of the date of grant was on Saturday, March 29, 2025, the vesting occurred on Monday, March 31, 2025, the next business day."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On March 29, 2024, RSUs were granted and on March 29, 2025, one-third of these RSUs vested, with the remaining RSUs to vest on March 29, 2026, and March 29, 2027. Since the first anniversary of the date of grant was on Saturday, March 29, 2025, the vesting occurred on Monday, March 31, 2025, the next business day."}],"balance_after":30142,"derivative":{"underlying":"Common Stock","underlying_shares":15070},"source":{"system":"sec-edgar","filing":"0001821825-25-000014","document":"wk-form4_1743630106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182525000014/wk-form4_1743630106.xml","form_type":"4"}},{"id":1182965,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-04-02T21:41:53.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":64640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU converts into one share of Organon common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Organon common stock for each RSU. On March 31, 2025, RSUs were granted and will vest in three equal installments on each of March 31, 2026, March 31, 2027, and March 31, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Organon common stock for each RSU. On March 31, 2025, RSUs were granted and will vest in three equal installments on each of March 31, 2026, March 31, 2027, and March 31, 2028."}],"balance_after":64640,"derivative":{"underlying":"Common Stock","underlying_shares":64640},"source":{"system":"sec-edgar","filing":"0001821825-25-000014","document":"wk-form4_1743630106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182525000014/wk-form4_1743630106.xml","form_type":"4"}},{"id":1182964,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-02T21:41:53.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":317656,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2026, March 31, 2027, and March 31, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2026, March 31, 2027, and March 31, 2028."}],"balance_after":317656,"derivative":{"exercise_price":14.89,"underlying":"Common Stock","underlying_shares":317656},"source":{"system":"sec-edgar","filing":"0001821825-25-000014","document":"wk-form4_1743630106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182525000014/wk-form4_1743630106.xml","form_type":"4"}},{"id":1182963,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-04-02T21:41:53.000Z","date":"2025-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":3819,"price":14.51,"value":55413.69,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the closing market price of Organon & Co. (\"Organon\") common stock on Friday, March 28, 2025, as required by the plan under which the Restricted Stock Units (\"RSU\") were awarded."}],"balance_after":133084,"source":{"system":"sec-edgar","filing":"0001821825-25-000014","document":"wk-form4_1743630106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182525000014/wk-form4_1743630106.xml","form_type":"4"}},{"id":1182962,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-04-02T21:41:53.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":true,"shares":7754,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":136903,"source":{"system":"sec-edgar","filing":"0001821825-25-000014","document":"wk-form4_1743630106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182525000014/wk-form4_1743630106.xml","form_type":"4"}},{"id":1182961,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-04-02T21:41:53.000Z","date":"2025-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":5933,"price":14.51,"value":86087.83,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the closing market price of Organon & Co. (\"Organon\") common stock on Friday, March 28, 2025, as required by the plan under which the Restricted Stock Units (\"RSU\") were awarded."}],"balance_after":129149,"source":{"system":"sec-edgar","filing":"0001821825-25-000014","document":"wk-form4_1743630106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182525000014/wk-form4_1743630106.xml","form_type":"4"}},{"id":1182960,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-04-02T21:41:53.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":true,"shares":12046,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":135082,"source":{"system":"sec-edgar","filing":"0001821825-25-000014","document":"wk-form4_1743630106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182525000014/wk-form4_1743630106.xml","form_type":"4"}},{"id":1182959,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-04-02T21:41:53.000Z","date":"2025-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":7422,"price":14.51,"value":107693.22,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the closing market price of Organon & Co. (\"Organon\") common stock on Friday, March 28, 2025, as required by the plan under which the Restricted Stock Units (\"RSU\") were awarded."}],"balance_after":123036,"source":{"system":"sec-edgar","filing":"0001821825-25-000014","document":"wk-form4_1743630106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182525000014/wk-form4_1743630106.xml","form_type":"4"}},{"id":1182958,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-04-02T21:41:53.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":true,"shares":15070,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":130458,"source":{"system":"sec-edgar","filing":"0001821825-25-000014","document":"wk-form4_1743630106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182525000014/wk-form4_1743630106.xml","form_type":"4"}},{"id":1249266,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-24T22:09:12.000Z","date":"2025-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":1908,"price":15.29,"value":29173.32,"ownership":{"direct":true},"balance_after":115388,"source":{"system":"sec-edgar","filing":"0001821825-25-000004","document":"wk-form4_1740434946.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182525000004/wk-form4_1740434946.xml","form_type":"4"}},{"id":1249265,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-24T22:09:12.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":5570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares of Common Stock released to cover the dividend equivalents earned on the PSUs released above."}],"balance_after":117296,"source":{"system":"sec-edgar","filing":"0001821825-25-000004","document":"wk-form4_1740434946.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182525000004/wk-form4_1740434946.xml","form_type":"4"}},{"id":1249264,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-24T22:09:12.000Z","date":"2025-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":10662,"price":14.92,"value":159077.04,"ownership":{"direct":true},"balance_after":111726,"source":{"system":"sec-edgar","filing":"0001821825-25-000004","document":"wk-form4_1740434946.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182525000004/wk-form4_1740434946.xml","form_type":"4"}},{"id":1249263,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-24T22:09:12.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":30414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Organon & Co. common stock (\"Common Stock\") for performance share units (\"PSUs\") granted to the reporting person on August 09, 2022 under the Organon & Co. 2021 Incentive Stock Plan. The performance-vesting restrictions with respect to these shares were released upon certification of performance goal attainment by the Talent Committee of Organon's Board of Directors."}],"balance_after":122388,"source":{"system":"sec-edgar","filing":"0001821825-25-000004","document":"wk-form4_1740434946.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182525000004/wk-form4_1740434946.xml","form_type":"4"}},{"id":1413685,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-05T20:31:15.000Z","date":"2024-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":3541,"price":20.35,"value":72059.35,"ownership":{"direct":true},"balance_after":91974,"source":{"system":"sec-edgar","filing":"0001821825-24-000098","document":"wk-form4_1725568268.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182524000098/wk-form4_1725568268.xml","form_type":"4"}},{"id":1413684,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-05T20:31:15.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":7189,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Organon & Co. common stock for performance share units granted to the reporting person on August 17, 2021 under the Organon & Co. 2021 Incentive Stock Plan. The performance-vesting restrictions with respect to these shares were released upon certification of performance goal attainment by the Talent Committee of Organon's Board of Directors."}],"balance_after":95515,"source":{"system":"sec-edgar","filing":"0001821825-24-000098","document":"wk-form4_1725568268.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182524000098/wk-form4_1725568268.xml","form_type":"4"}},{"id":1503467,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-23T20:45:02.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":11928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU was granted on May 21, 2024, under the Incentive Plan that entitles the reporting person to receive one share of issuer's common stock per RSU. The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each RSU was granted on May 21, 2024, under the Incentive Plan that entitles the reporting person to receive one share of issuer's common stock per RSU. The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each RSU was granted on May 21, 2024, under the Incentive Plan that entitles the reporting person to receive one share of issuer's common stock per RSU. The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual meeting."}],"balance_after":11928,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11928},"source":{"system":"sec-edgar","filing":"0001415889-24-014298","document":"form4-05232024_080552.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000141588924014298/form4-05232024_080552.xml","form_type":"4"}},{"id":1503466,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-23T20:45:02.000Z","date":"2024-05-21","kind":"exercise","planned":false,"acquired":false,"shares":8663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 23, 2023, under Certara, Inc.'s 2020 Incentive Plan (\"Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 21, 2024, the day of the issuer's annual meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 23, 2023, under Certara, Inc.'s 2020 Incentive Plan (\"Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 21, 2024, the day of the issuer's annual meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 23, 2023, under Certara, Inc.'s 2020 Incentive Plan (\"Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 21, 2024, the day of the issuer's annual meeting."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8663},"source":{"system":"sec-edgar","filing":"0001415889-24-014298","document":"form4-05232024_080552.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000141588924014298/form4-05232024_080552.xml","form_type":"4"}},{"id":1503465,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-23T20:45:02.000Z","date":"2024-05-21","kind":"exercise","planned":false,"acquired":true,"shares":8663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 23, 2023, under Certara, Inc.'s 2020 Incentive Plan (\"Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 21, 2024, the day of the issuer's annual meeting."}],"balance_after":185631,"source":{"system":"sec-edgar","filing":"0001415889-24-014298","document":"form4-05232024_080552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000141588924014298/form4-05232024_080552.xml","form_type":"4"}},{"id":1524541,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-05-07T20:05:02.000Z","date":"2024-05-04","kind":"exercise","planned":false,"acquired":false,"shares":8310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On each of May 4, 2022, May 4, 2023 and May 4, 2024, one-third of the RSUs vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On each of May 4, 2022, May 4, 2023 and May 4, 2024, one-third of the RSUs vested."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8310},"source":{"system":"sec-edgar","filing":"0001821825-24-000058","document":"wk-form4_1715112284.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182524000058/wk-form4_1715112284.xml","form_type":"4"}},{"id":1524540,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-07T20:05:02.000Z","date":"2024-05-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":4093,"price":19.61,"value":80263.73,"ownership":{"direct":true},"balance_after":88326,"source":{"system":"sec-edgar","filing":"0001821825-24-000058","document":"wk-form4_1715112284.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182524000058/wk-form4_1715112284.xml","form_type":"4"}},{"id":1524539,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-07T20:05:02.000Z","date":"2024-05-04","kind":"exercise","planned":false,"acquired":true,"shares":8310,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":92419,"source":{"system":"sec-edgar","filing":"0001821825-24-000058","document":"wk-form4_1715112284.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182524000058/wk-form4_1715112284.xml","form_type":"4"}},{"id":1549049,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-04-03T22:42:08.000Z","date":"2024-03-31","kind":"exercise","planned":false,"acquired":false,"shares":12046,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit converts into one share of Organon & Co. (\"Organon\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 31, 2024, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2025 and March 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On March 31, 2024, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2025 and March 31, 2026."}],"balance_after":24093,"derivative":{"underlying":"Common Stock","underlying_shares":12046},"source":{"system":"sec-edgar","filing":"0001821825-24-000049","document":"wk-form4_1712184118.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182524000049/wk-form4_1712184118.xml","form_type":"4"}},{"id":1549048,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-04-03T22:42:08.000Z","date":"2024-03-31","kind":"exercise","planned":false,"acquired":false,"shares":7753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit converts into one share of Organon & Co. (\"Organon\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon common stock for each RSU. On each of March 31, 2023, and March 31, 2024, one-third of the RSUs vested, with the remaining RSUs to vest on March 31, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon common stock for each RSU. On each of March 31, 2023, and March 31, 2024, one-third of the RSUs vested, with the remaining RSUs to vest on March 31, 2025."}],"balance_after":7754,"derivative":{"underlying":"Common Stock","underlying_shares":7753},"source":{"system":"sec-edgar","filing":"0001821825-24-000049","document":"wk-form4_1712184118.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182524000049/wk-form4_1712184118.xml","form_type":"4"}},{"id":1549047,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-03T22:42:08.000Z","date":"2024-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":5933,"price":18.8,"value":111540.4,"ownership":{"direct":true},"balance_after":84109,"source":{"system":"sec-edgar","filing":"0001821825-24-000049","document":"wk-form4_1712184118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182524000049/wk-form4_1712184118.xml","form_type":"4"}},{"id":1549046,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-03T22:42:08.000Z","date":"2024-03-31","kind":"exercise","planned":false,"acquired":true,"shares":12046,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":90042,"source":{"system":"sec-edgar","filing":"0001821825-24-000049","document":"wk-form4_1712184118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182524000049/wk-form4_1712184118.xml","form_type":"4"}},{"id":1549045,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-03T22:42:08.000Z","date":"2024-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":3819,"price":18.8,"value":71797.2,"ownership":{"direct":true},"balance_after":77996,"source":{"system":"sec-edgar","filing":"0001821825-24-000049","document":"wk-form4_1712184118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182524000049/wk-form4_1712184118.xml","form_type":"4"}},{"id":1549044,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-03T22:42:08.000Z","date":"2024-03-31","kind":"exercise","planned":false,"acquired":true,"shares":7753,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":81815,"source":{"system":"sec-edgar","filing":"0001821825-24-000049","document":"wk-form4_1712184118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182524000049/wk-form4_1712184118.xml","form_type":"4"}},{"id":1553052,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-02T20:12:04.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":185185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027."}],"balance_after":185185,"derivative":{"exercise_price":18.8,"exercise_date":"2025-03-29","expiration_date":"2027-03-29","underlying":"Common Stock","underlying_shares":185185},"source":{"system":"sec-edgar","filing":"0001821825-24-000018","document":"wk-form4_1712088709.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182524000018/wk-form4_1712088709.xml","form_type":"4"}},{"id":1553051,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-04-02T20:12:04.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":45212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027."}],"balance_after":45212,"derivative":{"exercise_date":"2025-03-29","expiration_date":"2027-03-29","underlying":"Common Stock","underlying_shares":45212},"source":{"system":"sec-edgar","filing":"0001821825-24-000018","document":"wk-form4_1712088709.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182524000018/wk-form4_1712088709.xml","form_type":"4"}},{"id":1606694,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-01T21:24:13.000Z","date":"2024-02-28","kind":"exercise","planned":false,"acquired":false,"shares":33044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit converts into one share of Organon & Co. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"As previously reported, these Restricted Stock Units vested on December 31, 2023, and shares of Organon & Co. common stock were distributed to the Reporting Person on February 28, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"As previously reported, these Restricted Stock Units vested on December 31, 2023, and shares of Organon & Co. common stock were distributed to the Reporting Person on February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"As previously reported, these Restricted Stock Units vested on December 31, 2023, and shares of Organon & Co. common stock were distributed to the Reporting Person on February 28, 2024."}],"balance_after":0,"derivative":{"exercise_date":"2023-12-31","expiration_date":"2023-12-31","underlying":"Common Stock","underlying_shares":33044},"source":{"system":"sec-edgar","filing":"0001821825-24-000011","document":"wk-form4_1709328243.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182524000011/wk-form4_1709328243.xml","form_type":"4"}},{"id":1606693,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-01T21:24:13.000Z","date":"2024-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":11393,"price":18.04,"value":205529.72,"ownership":{"direct":true},"balance_after":74062,"source":{"system":"sec-edgar","filing":"0001821825-24-000011","document":"wk-form4_1709328243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182524000011/wk-form4_1709328243.xml","form_type":"4"}},{"id":1606692,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-01T21:24:13.000Z","date":"2024-02-28","kind":"exercise","planned":false,"acquired":true,"shares":33044,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit converts into one share of Organon & Co. common stock."}],"balance_after":85455,"source":{"system":"sec-edgar","filing":"0001821825-24-000011","document":"wk-form4_1709328243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000182182524000011/wk-form4_1709328243.xml","form_type":"4"}},{"id":1812827,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-08-08T22:07:24.000Z","date":"2023-08-05","kind":"exercise","planned":false,"acquired":false,"shares":22347,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On each of August 5, 2021, August 5, 2022 and August 5, 2023, one-third of the RSUs vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On each of August 5, 2021, August 5, 2022 and August 5, 2023, one-third of the RSUs vested."}],"balance_after":0,"derivative":{"exercise_date":"2023-08-05","expiration_date":"2023-08-05","underlying":"Common Stock","underlying_shares":22347},"source":{"system":"sec-edgar","filing":"0001209191-23-045067","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000120919123045067/doc4.xml","form_type":"4"}},{"id":1812826,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-08T22:07:24.000Z","date":"2023-08-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":11006,"price":21.53,"value":236959.18,"ownership":{"direct":true},"balance_after":52411,"source":{"system":"sec-edgar","filing":"0001209191-23-045067","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000120919123045067/doc4.xml","form_type":"4"}},{"id":1812825,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-08T22:07:24.000Z","date":"2023-08-05","kind":"exercise","planned":false,"acquired":true,"shares":22347,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU."}],"balance_after":63417,"source":{"system":"sec-edgar","filing":"0001209191-23-045067","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000120919123045067/doc4.xml","form_type":"4"}},{"id":1877840,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-25T12:48:10.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":8663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on May 23, 2023, under the Certara Inc. 2020 Incentive Plan that entitles the reporting person to receive one share of the issuer's common stock per RSU.  The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual shareholder meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on May 23, 2023, under the Certara Inc. 2020 Incentive Plan that entitles the reporting person to receive one share of the issuer's common stock per RSU.  The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual shareholder meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on May 23, 2023, under the Certara Inc. 2020 Incentive Plan that entitles the reporting person to receive one share of the issuer's common stock per RSU.  The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual shareholder meeting."}],"balance_after":8663,"derivative":{"underlying":"Common Stock","underlying_shares":8663},"source":{"system":"sec-edgar","filing":"0001415889-23-008752","document":"form4-05252023_120506.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000141588923008752/form4-05252023_120506.xml","form_type":"4"}},{"id":1884334,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-19T12:36:22.000Z","date":"2023-05-17","kind":"exercise","planned":false,"acquired":false,"shares":9067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted under the Certara, Inc. 2020 Incentive Plan that entitles the reporting person to receive one share of the Issuer's Common Stock per RSU.  The RSUs vested and were converted into common shares on the one-year anniversary of the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted under the Certara, Inc. 2020 Incentive Plan that entitles the reporting person to receive one share of the Issuer's Common Stock per RSU.  The RSUs vested and were converted into common shares on the one-year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted under the Certara, Inc. 2020 Incentive Plan that entitles the reporting person to receive one share of the Issuer's Common Stock per RSU.  The RSUs vested and were converted into common shares on the one-year anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9067},"source":{"system":"sec-edgar","filing":"0001415889-23-008306","document":"form4-05192023_120517.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000141588923008306/form4-05192023_120517.xml","form_type":"4"}},{"id":1884333,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-19T12:36:22.000Z","date":"2023-05-17","kind":"exercise","planned":false,"acquired":true,"shares":9067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted under the Certara, Inc. 2020 Incentive Plan that entitles the reporting person to receive one share of the Issuer's Common Stock per RSU.  The RSUs vested and were converted into common shares on the one-year anniversary of the date of grant."}],"balance_after":176968,"source":{"system":"sec-edgar","filing":"0001415889-23-008306","document":"form4-05192023_120517.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000141588923008306/form4-05192023_120517.xml","form_type":"4"}},{"id":1900783,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-05-08T22:46:14.000Z","date":"2023-05-04","kind":"exercise","planned":false,"acquired":false,"shares":8310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"1. The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"1. The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024."}],"balance_after":8310,"derivative":{"exercise_date":"2023-05-04","expiration_date":"2024-05-04","underlying":"Common Stock","underlying_shares":8310},"source":{"system":"sec-edgar","filing":"0001209191-23-028105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000120919123028105/doc4.xml","form_type":"4"}},{"id":1900782,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-08T22:46:14.000Z","date":"2023-05-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":4043,"price":24.24,"value":98002.32,"ownership":{"direct":true},"balance_after":41070,"source":{"system":"sec-edgar","filing":"0001209191-23-028105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000120919123028105/doc4.xml","form_type":"4"}},{"id":1900781,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-08T22:46:14.000Z","date":"2023-05-04","kind":"exercise","planned":false,"acquired":true,"shares":8310,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1. The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024."}],"balance_after":45113,"source":{"system":"sec-edgar","filing":"0001209191-23-028105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000120919123028105/doc4.xml","form_type":"4"}},{"id":1927434,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-05T00:21:21.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":129770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2024, March 31, 2025 and March 31, 2026."}],"balance_after":129770,"derivative":{"exercise_price":23.52,"exercise_date":"2024-03-31","expiration_date":"2033-03-31","underlying":"Common Stock","underlying_shares":129770},"source":{"system":"sec-edgar","filing":"0001209191-23-023087","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000120919123023087/doc4.xml","form_type":"4"}},{"id":1927433,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-04-05T00:21:21.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":36139,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon common stock for each RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 31, 2024, March 31, 2025 and March 31, 2026."}],"balance_after":36139,"derivative":{"exercise_date":"2024-03-31","expiration_date":"2026-03-31","underlying":"Common Stock","underlying_shares":36139},"source":{"system":"sec-edgar","filing":"0001209191-23-023087","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000120919123023087/doc4.xml","form_type":"4"}},{"id":1927432,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-04-05T00:21:21.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":false,"shares":7753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit converts into one share of Organon & Co. (\"Organon\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 31, 2023, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2024 and March 31, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 31, 2023, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2024 and March 31, 2025."}],"balance_after":15507,"derivative":{"underlying":"Common Stock","underlying_shares":7753},"source":{"system":"sec-edgar","filing":"0001209191-23-023087","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000120919123023087/doc4.xml","form_type":"4"}},{"id":1927431,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-04-05T00:21:21.000Z","date":"2023-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":2656,"price":23.09,"value":61327.04,"ownership":{"direct":true},"balance_after":36803,"source":{"system":"sec-edgar","filing":"0001209191-23-023087","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000120919123023087/doc4.xml","form_type":"4"}},{"id":1927430,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-04-05T00:21:21.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":true,"shares":7753,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39459,"source":{"system":"sec-edgar","filing":"0001209191-23-023087","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000120919123023087/doc4.xml","form_type":"4"}},{"id":2115964,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-15T21:50:04.000Z","date":"2022-11-14","kind":"sale","acquired":false,"shares":12059,"price":14.74,"value":177749.66,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $14.66 to $14.88. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":167901,"source":{"system":"sec-edgar","filing":"0001415889-22-011400","document":"form4-11152022_091148.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000141588922011400/form4-11152022_091148.xml","form_type":"4"}},{"id":2190651,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-08-09T23:52:42.000Z","date":"2022-08-05","kind":"exercise","acquired":false,"shares":22343,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU."},{"field":"shares","element":"transactionShares","label":"F2","text":"The total amount of the RSUs has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On each of August 5, 2021 and August 5, 2022, one-third of the RSUs vested with the remaining RSUs to vest in one final installment on August 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On each of August 5, 2021 and August 5, 2022, one-third of the RSUs vested with the remaining RSUs to vest in one final installment on August 5, 2023."}],"balance_after":22343,"derivative":{"exercise_date":"2022-08-05","expiration_date":"2023-08-05","underlying":"Common Stock","underlying_shares":22343},"source":{"system":"sec-edgar","filing":"0001104659-22-088173","document":"tm2222874-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000110465922088173/tm2222874-1_4seq1.xml","form_type":"4"}},{"id":2190650,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-09T23:52:42.000Z","date":"2022-08-05","kind":"tax_withholding","acquired":false,"shares":10790,"price":32.41,"value":349703.9,"ownership":{"direct":true},"balance_after":31706,"source":{"system":"sec-edgar","filing":"0001104659-22-088173","document":"tm2222874-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000110465922088173/tm2222874-1_4seq1.xml","form_type":"4"}},{"id":2190649,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-09T23:52:42.000Z","date":"2022-08-05","kind":"exercise","acquired":true,"shares":22343,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU."}],"balance_after":42496,"source":{"system":"sec-edgar","filing":"0001104659-22-088173","document":"tm2222874-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000110465922088173/tm2222874-1_4seq1.xml","form_type":"4"}},{"id":2265431,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-18T20:42:03.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":9067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of common stock."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents 9,067 RSUs granted under the Certara Inc. 2020 Incentive Plan that will entitle the reporting person to receive one share of the Issuer's Common Stock per RSU. The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Company's next annual shareholder meeting. The reporting person has reported prior awards of RSUs in Table 1 of Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Company's next annual shareholder meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Company's next annual shareholder meeting."}],"balance_after":9067,"derivative":{"underlying":"Common Stock","underlying_shares":9067},"source":{"system":"sec-edgar","filing":"0001415889-22-005247","document":"form4-05182022_010541.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000141588922005247/form4-05182022_010541.xml","form_type":"4"}},{"id":2280661,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-05-06T00:53:09.000Z","date":"2022-05-04","kind":"exercise","acquired":false,"shares":8310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024."}],"balance_after":8310,"derivative":{"exercise_date":"2022-05-04","expiration_date":"2024-05-04","underlying":"Common Stock","underlying_shares":8310},"source":{"system":"sec-edgar","filing":"0001104659-22-056635","document":"tm2214603-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000110465922056635/tm2214603-10_4seq1.xml","form_type":"4"}},{"id":2280660,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-06T00:53:09.000Z","date":"2022-05-04","kind":"tax_withholding","acquired":false,"shares":2847,"price":32.44,"value":92356.68,"ownership":{"direct":true},"balance_after":20153,"source":{"system":"sec-edgar","filing":"0001104659-22-056635","document":"tm2214603-10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000110465922056635/tm2214603-10_4seq1.xml","form_type":"4"}},{"id":2280659,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-06T00:53:09.000Z","date":"2022-05-04","kind":"exercise","acquired":true,"shares":8310,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU."}],"balance_after":23000,"source":{"system":"sec-edgar","filing":"0001104659-22-056635","document":"tm2214603-10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000110465922056635/tm2214603-10_4seq1.xml","form_type":"4"}},{"id":2307797,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-04-04T22:11:16.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":71649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2023, March 31, 2024 and March 31, 2025."}],"balance_after":71649,"derivative":{"exercise_price":34.93,"exercise_date":"2023-03-31","expiration_date":"2032-03-29","underlying":"Common Stock","underlying_shares":71649},"source":{"system":"sec-edgar","filing":"0001104659-22-042363","document":"tm2211465-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000110465922042363/tm2211465-8_4seq1.xml","form_type":"4"}},{"id":2307796,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-04-04T22:11:16.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":23260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 31, 2023, March 31, 2024 and March 31, 2025."}],"balance_after":23260,"derivative":{"exercise_date":"2023-03-31","expiration_date":"2025-03-31","underlying":"Common Stock","underlying_shares":23260},"source":{"system":"sec-edgar","filing":"0001104659-22-042363","document":"tm2211465-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000110465922042363/tm2211465-8_4seq1.xml","form_type":"4"}},{"id":2595951,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-19T21:08:39.000Z","date":"2021-08-17","kind":"grant","acquired":true,"shares":44642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in three equal installments on August 17, 2022, August 17, 2023 and August 17, 2024."}],"balance_after":44642,"derivative":{"exercise_price":35.38,"exercise_date":"2022-08-17","expiration_date":"2031-08-16","underlying":"Common Stock","underlying_shares":44642},"source":{"system":"sec-edgar","filing":"0000899243-21-033670","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000089924321033670/doc4.xml","form_type":"4"}},{"id":2609907,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-08-09T20:44:00.000Z","date":"2021-08-05","kind":"exercise","acquired":true,"shares":22343,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Organon & Co. (\"Organon\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units vest and are distributed as shares of Organon common stock in three equal installments on August 5, 2021, August 5, 2022 and August 5, 2023."}],"balance_after":44690,"derivative":{"exercise_date":"2021-08-05","expiration_date":"2023-08-05","underlying":"Common Stock","underlying_shares":22343},"source":{"system":"sec-edgar","filing":"0000899243-21-032176","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000089924321032176/doc4.xml","form_type":"4"}},{"id":2609906,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-09T20:44:00.000Z","date":"2021-08-05","kind":"tax_withholding","acquired":false,"shares":7653,"price":28.63,"value":219105.39,"ownership":{"direct":true},"balance_after":14690,"source":{"system":"sec-edgar","filing":"0000899243-21-032176","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000089924321032176/doc4.xml","form_type":"4"}},{"id":2609905,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-09T20:44:00.000Z","date":"2021-08-05","kind":"exercise","acquired":true,"shares":22343,"price":28.63,"value":639680.09,"ownership":{"direct":true},"balance_after":22343,"source":{"system":"sec-edgar","filing":"0000899243-21-032176","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000089924321032176/doc4.xml","form_type":"4"}},{"id":2680715,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-05T01:16:08.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":193302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"In connection with the Separation, each outstanding Merck stock option was converted into an award of options to purchase shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of shares and exercise price of each option award was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck stock option. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vests and becomes exercisable in three equal installments on May 4, 2022, May 4, 2023 and May 4, 2024."}],"balance_after":193302,"derivative":{"exercise_price":36.11,"exercise_date":"2022-05-04","expiration_date":"2031-05-03","underlying":"Common Stock","underlying_shares":193302},"source":{"system":"sec-edgar","filing":"0000899243-21-022182","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000089924321022182/doc4.xml","form_type":"4"}},{"id":2680714,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-06-05T01:16:08.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":33044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Organon & Co. (\"Organon\") common stock."},{"field":"kind","element":"transactionCoding","label":"F5","text":"In connection with the Separation, each outstanding Merck performance stock unit award was converted into a restricted stock unit award denominated in shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck performance stock unit award. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These restricted stock units vest and are distributed as shares of Organon common stock in a single installment on December 31, 2023."}],"balance_after":33044,"derivative":{"exercise_date":"2023-12-31","expiration_date":"2023-12-31","underlying":"Common Stock","underlying_shares":33044},"source":{"system":"sec-edgar","filing":"0000899243-21-022182","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000089924321022182/doc4.xml","form_type":"4"}},{"id":2680713,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-06-05T01:16:08.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":24930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Organon & Co. (\"Organon\") common stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with the separation (the \"Separation\") of Organon from Merck & Co., Inc. (\"Merck\"), each outstanding Merck restricted stock unit award was converted into a restricted stock unit award denominated in shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck restricted stock unit award. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units vest and are distributed as shares of Organon common stock in three equal installments on May 4, 2022, May 4, 2023 and May 4, 2024."}],"balance_after":24930,"derivative":{"exercise_date":"2022-05-04","expiration_date":"2024-05-04","underlying":"Common Stock","underlying_shares":24930},"source":{"system":"sec-edgar","filing":"0000899243-21-022182","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000089924321022182/doc4.xml","form_type":"4"}},{"id":2680712,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-06-05T01:16:08.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":67033,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Organon & Co. (\"Organon\") common stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with the separation (the \"Separation\") of Organon from Merck & Co., Inc. (\"Merck\"), each outstanding Merck restricted stock unit award was converted into a restricted stock unit award denominated in shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck restricted stock unit award. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units vest and are distributed as shares of Organon common stock in three equal installments on August 5, 2021, August 5, 2022 and August 5, 2023."}],"balance_after":67033,"derivative":{"exercise_date":"2021-08-05","expiration_date":"2023-08-05","underlying":"Common Stock","underlying_shares":67033},"source":{"system":"sec-edgar","filing":"0000899243-21-022182","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000089924321022182/doc4.xml","form_type":"4"}},{"id":2707616,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-18T20:52:30.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":7059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents 7,059 restricted stock units (\"RSU\") granted under the Certara Inc. 2020 Incentive Plan that will entitle the reporting person to receive one share of the Issuer's Common Stock per RSU. The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Company's next annual stockholder meeting."}],"balance_after":179960,"source":{"system":"sec-edgar","filing":"0001104659-21-068896","document":"tm2116784-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000110465921068896/tm2116784-4_4seq1.xml","form_type":"4"}},{"id":2942233,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T23:58:38.000Z","date":"2020-12-15","kind":"purchase","acquired":true,"shares":5000,"price":23,"value":115000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares were acquired in a directed share program in connection with the Issuer's initial public offering."}],"balance_after":172901,"source":{"system":"sec-edgar","filing":"0001104659-20-136447","document":"tm2038646-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000110465920136447/tm2038646-2_4seq1.xml","form_type":"4"}},{"id":2942232,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T23:58:38.000Z","date":"2020-12-10","kind":"grant","acquired":true,"shares":145597,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents restricted stock previously granted to the reporting person on December 10, 2020. These shares of restricted stock were already reflected on the reporting person's previously filed Form 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents restricted stock previously granted to the reporting person on December 10, 2020. These shares of restricted stock were already reflected on the reporting person's previously filed Form 3."}],"balance_after":167901,"source":{"system":"sec-edgar","filing":"0001104659-20-136447","document":"tm2038646-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000110465920136447/tm2038646-2_4seq1.xml","form_type":"4"}},{"id":2942231,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T23:58:38.000Z","date":"2020-12-10","kind":"other","acquired":true,"shares":22304,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the receipt of shares of common stock of the Issuer from EQT Avatar Parent L.P. in exchange for units in EQT Avatar Parent L.P. previously held by the reporting person. These shares of common stock were already reflected on the reporting person's previously filed Form 3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the receipt of shares of common stock of the Issuer from EQT Avatar Parent L.P. in exchange for units in EQT Avatar Parent L.P. previously held by the reporting person. These shares of common stock were already reflected on the reporting person's previously filed Form 3."}],"balance_after":22304,"source":{"system":"sec-edgar","filing":"0001104659-20-136447","document":"tm2038646-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000110465920136447/tm2038646-2_4seq1.xml","form_type":"4"}},{"id":3154227,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Performance Stock Units","published_at":"2020-05-12T01:44:48.000Z","date":"2020-05-08","kind":"disposition_to_issuer","acquired":false,"shares":28021,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the disposition of performance stock units relating to Allergan Shares (\"Allergan PSUs\") as contemplated by the Transaction Agreement.  In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, was substituted by AbbVie with an AbbVie restricted stock unit award relating to shares of AbbVie common stock, that vests based on the holder's continued service following the effective time of the Scheme, with the number of shares of AbbVie common stock subject to such award determined in accordance with the formulas set forth in the Transaction Agreement (which, for any Allergan performance stock unit awards that were subject to performance-based vesting conditions on June 25, 2019, was calculated based on deemed satisfaction of performance at 130% of target)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the disposition of performance stock units relating to Allergan Shares (\"Allergan PSUs\") as contemplated by the Transaction Agreement.  In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, was substituted by AbbVie with an AbbVie restricted stock unit award relating to shares of AbbVie common stock, that vests based on the holder's continued service following the effective time of the Scheme, with the number of shares of AbbVie common stock subject to such award determined in accordance with the formulas set forth in the Transaction Agreement (which, for any Allergan performance stock unit awards that were subject to performance-based vesting conditions on June 25, 2019, was calculated based on deemed satisfaction of performance at 130% of target)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects the disposition of performance stock units relating to Allergan Shares (\"Allergan PSUs\") as contemplated by the Transaction Agreement.  In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, was substituted by AbbVie with an AbbVie restricted stock unit award relating to shares of AbbVie common stock, that vests based on the holder's continued service following the effective time of the Scheme, with the number of shares of AbbVie common stock subject to such award determined in accordance with the formulas set forth in the Transaction Agreement (which, for any Allergan performance stock unit awards that were subject to performance-based vesting conditions on June 25, 2019, was calculated based on deemed satisfaction of performance at 130% of target)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the disposition of performance stock units relating to Allergan Shares (\"Allergan PSUs\") as contemplated by the Transaction Agreement.  In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, was substituted by AbbVie with an AbbVie restricted stock unit award relating to shares of AbbVie common stock, that vests based on the holder's continued service following the effective time of the Scheme, with the number of shares of AbbVie common stock subject to such award determined in accordance with the formulas set forth in the Transaction Agreement (which, for any Allergan performance stock unit awards that were subject to performance-based vesting conditions on June 25, 2019, was calculated based on deemed satisfaction of performance at 130% of target)."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":28021},"source":{"system":"sec-edgar","filing":"0000899243-20-012747","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000089924320012747/doc4.xml","form_type":"4"}},{"id":3154226,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-05-12T01:44:48.000Z","date":"2020-05-08","kind":"disposition_to_issuer","acquired":false,"shares":27618,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the disposition of restricted stock units relating to Allergan Shares (\"Allergan RSUs\") as contemplated by the Transaction Agreement.  In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, each Allergan RSU was substituted by AbbVie with a corresponding AbbVie restricted stock unit award relating to shares of AbbVie common stock, with the number of shares of AbbVie common stock subject to such award determined in accordance with the formula set forth in the Transaction Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-012747","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000089924320012747/doc4.xml","form_type":"4"}},{"id":3154225,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2020-05-12T01:44:48.000Z","date":"2020-05-08","kind":"disposition_to_issuer","acquired":false,"shares":12039,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the disposition of ordinary shares (\"Allergan Shares\") of Allergan plc (\"Allergan\") as contemplated by the Transaction Agreement dated as of June 25, 2019 among AbbVie Inc. (\"AbbVie\"), Venice Subsidiary, LLC (\"Acquirer Sub\") and Allergan (the \"Transaction Agreement\"), pursuant to which Acquirer Sub acquired Allergan pursuant to a scheme of arrangement under Chapter 1 of Part 9 of the Irish Companies Act of 2014 and the capital reduction under Sections 84 and 85 of the Act (the \"Scheme\").  In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, each Allergan Share was converted into $120.30 in cash and 0.8660 of a newly issued share of AbbVie common stock, par value $0.01 per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-012747","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000089924320012747/doc4.xml","form_type":"4"}},{"id":3227032,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Ordinary Shares, Par value $0.0001","published_at":"2020-03-04T19:17:30.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":15476,"price":193.84,"value":2999867.84,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units issued pursuant to the Amended and Restated Allergan, Inc. 2011 Incentive Award Plan."}],"balance_after":39657,"source":{"system":"sec-edgar","filing":"0001179110-20-003039","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000117911020003039/edgar.xml","form_type":"4"}},{"id":3641489,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Ordinary Shares, Par value $0.0001","published_at":"2019-02-21T22:41:19.000Z","date":"2019-02-20","kind":"tax_withholding","acquired":false,"shares":2235,"price":140.33,"value":313637.55,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units issued pursuant to the Amended and Restated Allergan, Inc. 2011 Incentive Award Plan."}],"balance_after":24181,"source":{"system":"sec-edgar","filing":"0001179110-19-002262","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000117911019002262/edgar.xml","form_type":"4"}},{"id":3758657,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Ordinary Shares, Par value $0.0001","published_at":"2018-11-20T00:22:22.000Z","date":"2018-11-16","kind":"purchase","acquired":true,"shares":1000,"price":157,"value":157000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted shares issued pursuant to the Amended and Restated Allergan, Inc. 2011 Incentive Award Plan."}],"balance_after":26416,"source":{"system":"sec-edgar","filing":"0000903423-18-000616","document":"walsh4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000090342318000616/walsh4.xml","form_type":"4"}},{"id":4005115,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2018-03-08T15:44:17.000Z","date":"2018-03-08","kind":"purchase","acquired":true,"shares":1000,"price":153.96,"value":153960.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":25416,"source":{"system":"sec-edgar","filing":"0001179110-18-003831","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000117911018003831/edgar.xml","form_type":"4"}},{"id":4039908,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":46859,"kind":"person","name":"WALSH MATTHEW M","position":1,"cik":"0001269428","reported_name":"WALSH MATTHEW M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2018-02-22T21:25:38.000Z","date":"2018-02-20","kind":"grant","acquired":true,"shares":28021,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Represents performance-based restricted share units (\"PSUs\") which will vest as to 50% of the total grant on each of December 31, 2020 and December 31, 2021, subject to the achievement by the Issuer of certain performance criteria. Each PSU represents a contingent right to receive a number of ordinary shares equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents performance-based restricted share units (\"PSUs\") which will vest as to 50% of the total grant on each of December 31, 2020 and December 31, 2021, subject to the achievement by the Issuer of certain performance criteria. Each PSU represents a contingent right to receive a number of ordinary shares equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Represents performance-based restricted share units (\"PSUs\") which will vest as to 50% of the total grant on each of December 31, 2020 and December 31, 2021, subject to the achievement by the Issuer of certain performance criteria. Each PSU represents a contingent right to receive a number of ordinary shares equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Represents performance-based restricted share units (\"PSUs\") which will vest as to 50% of the total grant on each of December 31, 2020 and December 31, 2021, subject to the achievement by the Issuer of certain performance criteria. Each PSU represents a contingent right to receive a number of ordinary shares equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and the Reporting Person."}],"balance_after":28021,"derivative":{"underlying":"Ordinary Shares","underlying_shares":28021},"source":{"system":"sec-edgar","filing":"0001179110-18-002591","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1269428/000117911018002591/edgar.xml","form_type":"4"}}],"next_cursor":"2018-02-22T21:25:38.000000Z,4039908"}